Mukta Kukreja

• Lead marketing strategy and product management for a broad healthcare portfolio spanning
geriatric and joint health, womens health and menopause, mens and urogenital health,
bone and mineral-deficiency (calcium, magnesium, vitamin D), paediatrics, and sleep,
digestive, cognitive and liver health.
• Authored ~18 scientific product backgrounders across these therapeutic areas — general,
market-agnostic documents analysing formulations, active ingredients and functional
additives, with a preventive, health-maintenance positioning.
• Conducted market sizing and competitive analysis for the Kazakhstan market — sourcing
primary scientific literature and mapping competitors — to position the portfolio as the
superior clinical choice.
• Developed the marketing and MR (medical-representative) training decks and HCP leave
behind leaflets for the October 2026 Kazakhstan launch (with Kyrgyzstan and Oman
planned), equipping the field force to sell the products and translate the science for
clinicians.
• Maintained brand consistency across all product materials and verified every scientific
reference against primary literature (PubMed) to safeguard clinical credibility.

• Relocated to Dubai, UAE, and transitioned from laboratory research toward commercial and
product roles in life sciences — a deliberate pivot that led to a Product Manager position at
Lunix.

• Long-read DNA extraction pipelines for human gut microbiome analysis
• Developed and optimised high-throughput DNA extraction and library-preparation pipelines,
increasing sequencing efficiency by 30% on NGS platforms.
• Programmed and maintained automated liquid-handling robotics (Maxwell RSC), reducing
human error in high-molecular-weight DNA extraction by 25%.
• Identified improved sample-preservation methods (e.g., Zymo Shield), raising DNA integrity
by 45% and enabling reliable long-read sequencing.
• Trained staff, students and visiting scientists in advanced molecular-biology techniques and
presented findings in regular team reviews.

• Fermentation & bioprocessing
• Managed large- and small-scale fermentation and bioreactor processes (5-L fermenter),
improving production capacity by 15% and reducing process downtime by 15%.
• Led 35+ experiments across media/buffer preparation, cell culture, purification and
equipment sterilisation under GMP-aligned standards.